BlackRock Inc. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,854,188
-47.4%
7,921,928
+5.9%
0.00%0.0%
Q2 2023$35,835,077
+1.1%
7,481,227
+19.7%
0.00%0.0%
Q1 2023$35,432,319
-2.0%
6,249,086
-3.2%
0.00%0.0%
Q4 2022$36,170,255
-10.6%
6,458,974
+2.5%
0.00%0.0%
Q3 2022$40,450,000
+104.7%
6,300,350
+9.4%
0.00%0.0%
Q2 2022$19,759,000
-52.9%
5,760,733
-2.3%
0.00%0.0%
Q1 2022$41,969,000
-14.1%
5,894,430
+0.5%
0.00%0.0%
Q4 2021$48,834,000
+20.1%
5,862,691
+0.3%
0.00%0.0%
Q3 2021$40,666,000
-73.4%
5,842,807
-9.0%
0.00%
-75.0%
Q2 2021$153,141,000
+21.0%
6,420,985
+4.5%
0.00%0.0%
Q1 2021$126,573,000
-17.7%
6,147,316
-2.0%
0.00%
-20.0%
Q4 2020$153,710,000
-9.8%
6,273,836
+4.2%
0.01%
-16.7%
Q3 2020$170,463,000
+689.9%
6,021,285
+32.8%
0.01%
+500.0%
Q2 2020$21,579,000
+53.1%
4,533,288
+14.8%
0.00%0.0%
Q1 2020$14,096,000
+2.1%
3,948,189
-1.4%
0.00%0.0%
Q4 2019$13,812,000
-13.9%
4,003,353
+0.1%
0.00%0.0%
Q3 2019$16,044,000
+114.5%
4,001,155
+72.2%
0.00%
Q2 2019$7,480,000
-50.5%
2,323,332
+5.6%
0.00%
-100.0%
Q1 2019$15,118,000
+48.2%
2,200,529
-2.5%
0.00%0.0%
Q4 2018$10,202,000
-41.1%
2,256,858
-1.1%
0.00%0.0%
Q3 2018$17,318,000
-10.1%
2,281,563
+1.8%
0.00%0.0%
Q2 2018$19,272,000
+44.1%
2,240,844
+23.0%
0.00%0.0%
Q1 2018$13,376,000
-28.9%
1,822,255
-1.8%
0.00%0.0%
Q4 2017$18,817,000
-38.6%
1,855,702
-2.9%
0.00%
-50.0%
Q3 2017$30,667,000
+46.7%
1,911,988
+3.4%
0.00%
+100.0%
Q2 2017$20,899,000
+9.1%
1,849,479
+8.8%
0.00%0.0%
Q1 2017$19,164,000
+106366.7%
1,700,385
+91515.6%
0.00%
Q4 2016$18,000
-53.8%
1,856
-42.7%
0.00%
Q3 2016$39,000
-72.9%
3,238
-34.4%
0.00%
Q2 2016$144,000
-88.8%
4,939
-89.8%
0.00%
-100.0%
Q1 2016$1,291,000
-23.0%
48,618
+1.7%
0.00%0.0%
Q4 2015$1,677,000
+2.7%
47,800
-13.2%
0.00%
-33.3%
Q3 2015$1,633,000
-28.6%
55,1000.0%0.00%0.0%
Q2 2015$2,287,00055,1000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders